• Explore /
  • Poster
  • / Randomized phase II trial of gemcitabine plus S−1 combination therapy versus S−1 in advanced biliary tract cancer: Results of the Japan Clinical Oncology Group study (JCOG0805).

Randomized phase II trial of gemcitabine plus S−1 combination therapy versus S−1 in advanced biliary tract cancer: Results of the Japan Clinical Oncology Group study (JCOG0805).

Abstract Poster

Authors

null

Makoto Ueno

Kanagawa Cancer Center Hospital, Yokohama, Japan

Makoto Ueno , Takuji Okusaka , Junki Mizusawa , Atsuo Takashima , Chigusa Morizane , Masafumi Ikeda , Yasuo Hamamoto , Hiroshi Ishii , Hiroki Hara , Akira Fukutomi , Masayuki Furukawa , Michitaka Nagase , Taketo Yamaguchi , Kenji Yamao , Shoji Nakamori , Tatsuya Ioka , Haruo Iguchi , Hiroyuki Miyakawa , Narikazu Boku , Junji Furuse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

UMIN000001685

Citation

J Clin Oncol 30, 2012 (suppl; abstr 4031)

DOI

10.1200/jco.2012.30.15_suppl.4031

Abstract #

4031

Poster Bd #

23

Abstract Disclosures

Similar Posters

First Author: Chigusa Morizane

First Author: John Ebben

First Author: Richard D. Kim

First Author: Arndt Vogel